학술논문 Archives - 52 중 2 번째 페이지 - 간 연구소

바로가기 메뉴: 본문 바로가기; 푸터 바로가기

Home
Login

사이트맵

TOP

Total 519건

번호 제목 작성자 조회수 작성일

109
Choi WM, Yu SJ, Ahn H, et al. A model to estimate survival in ambulatory patients with hepatocellular carcinoma: Can it predict the natural course of hepatocellular carcinoma? Dig Liver Dis 2017;49:1273-1279.
관리자 476 2018-03-22
108
Woo HG, Choi JH, Yoon S, et al. Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer. Nat Commun 2017;8:839.
관리자 424 2018-03-22
107
Chang Y, Choe WH, Sinn DH, et al. Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study. J Infect Dis 2017;216:1407-1414.
관리자 444 2018-03-22
106
Lee JH, Tak WY, Lee Y, et al. Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study. Oncoimmunology 2017;6:e1328335.
관리자 433 2018-03-22
105
Lim YS, Lee YS, Gwak GY, et al. Monotherapy with tenofovir disoproxil fumarate for multiple drug-resistant chronic hepatitis B: 3-year trial. Hepatology 2017;66:772-783.
관리자 394 2018-03-22
104
Kang SH, Lee YB, Lee JH, et al. Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy. Aliment Pharmacol Ther 2017;46:845-855.
관리자 424 2018-03-22
103
Kim H, Park J, Kim Y, et al. Serum fibronectin distinguishes the early stages of hepatocellular carcinoma. Sci Rep 2017;7:9449.
관리자 393 2018-03-22
102
Choi WM, Yu SJ, Ahn H, et al. A model to estimate survival in ambulatory patients with hepatocellular carcinoma: Can it predict the natural course of hepatocellular carcinoma? Dig Liver Dis 2017;49:1273-1279.
관리자 389 2018-03-22
101
Lee M, Chung GE, Lee JH, et al. Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment. Hepatology 2017;66:1556-1569.
관리자 396 2018-03-22
100
Kim H, Yu SJ, Yeo I, et al. Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS). Mol Cell Proteomics 2017;16:1312-1323.
관리자 475 2018-03-22

처음으로 이전 414243 44 45 46 47 48 49 50 다음 마지막으로

교육기관01

교육기관01
교육기관02
교육기관03

학과01
학과02
학과03

대학 · 대학원03

대학 · 대학원01
대학 · 대학원02
대학 · 대학원03

서울대학교 간연구소

서울시 종로구 연건동 28번지 서울의대 간연구소

TEL: 02-740-8112, FAX: 02-743-6701

COPYRIGHT (C)2023 Liver Research Institute, Seoul National University